It said the company intends to roll out the availability of its testing by March 30. The United States is not even close to meeting domestic demand for coronavirus testing. Many medical experts have predicted that delayed and chaotic testing will cost lives, potentially including those of doctors and nurses. The diagnostic test for the virus that causes COVID-19 has been designed to operate on any of Cepheid's more than 23,000 automated GeneXpert Systems globally, the company said. The company did not give further details or say how much the test will cost.

Source: bd News24 March 22, 2020 00:00 UTC